The Peter Attia Drive

Snapshot · The Peter Attia Drive

#403 ‒ Peptides: separating scientific promise from marketing hype

Explore episode Aug 10, 2026

Where this was said

Evaluating BPC-157: unclear mechanisms, absent human evidence, and unknown risks

At 17:34 · chapter starts 14:00

Peter applies his framework to BPC-157 — the poster child, he says, for everything that should make you skeptical of a peptide. On mechanism: the alleged parent protein has never been fully characterized, and the discoverer has refused to publish the screening method used to identify the compound, saying 'if you have your own child, you want it to be yours forever.' That's not missing data; that's deliberately withheld data — the scientific equivalent of 'trust me, bro.' Several mechanisms involving VEGF and nitric oxide have been proposed but none established in humans, and the primary receptor or target remains unknown. On human evidence: over 80% of the published literature comes from a single academic group with IP and commercial interests in the molecule, and independent replication is astonishingly thin. After approximately three decades of claims, there are no published peer-reviewed human RCTs. On safety and pharmacokinetics: human bioavailability is unknown, dosing protocols are guesses, and long-term risks have not been adequately studied. The risk-benefit calculation is also concerning: if BPC-157 truly stimulates VEGF and nitric oxide pathways as proponents claim, those are exactly the pathways that potentiate tumor biology. The conclusion: BPC-157 belongs firmly in Bucket 1.

Similar snapshots

Health & Fitness
Pipe broke → hydrogen sulfide studio air

Tortilla Face · Aug 10, 2026

A broken pipe filled the Bad Friends studio with what the hosts identified as hydrogen sulfide — microscopic fecal aeroparticles — that the crew denied smelling.